CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 102 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2018. The put-call ratio across all filers is 2.89 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $89,465,000 | -18.0% | 38,397 | 0.0% | 0.00% | – |
| Q4 2017 | $109,047,000 | -0.7% | 38,397 | 0.0% | 0.00% | – |
| Q3 2017 | $109,815,000 | +15.8% | 38,397 | 0.0% | 0.00% | – |
| Q2 2017 | $94,841,000 | -66.3% | 38,397 | -50.8% | 0.00% | – |
| Q1 2017 | $281,778,000 | +207089.7% | 78,055 | +103.3% | 0.00% | – |
| Q4 2016 | $136,000 | -29.9% | 38,397 | -20.0% | 0.00% | – |
| Q3 2016 | $194,000 | -8.1% | 47,997 | 0.0% | 0.00% | – |
| Q2 2016 | $211,000 | -5.4% | 47,997 | -18.7% | 0.00% | – |
| Q1 2016 | $223,000 | -98.6% | 59,046 | -94.4% | 0.00% | -100.0% |
| Q4 2015 | $16,398,000 | +27.2% | 1,045,813 | -14.5% | 0.02% | +35.7% |
| Q3 2015 | $12,891,000 | -56.2% | 1,223,015 | +4.7% | 0.01% | -50.0% |
| Q2 2015 | $29,458,000 | -6.8% | 1,168,057 | +3.0% | 0.03% | -6.7% |
| Q1 2015 | $31,595,000 | +84.7% | 1,133,627 | +21.0% | 0.03% | +87.5% |
| Q4 2014 | $17,102,000 | +84.1% | 937,127 | +30.7% | 0.02% | +77.8% |
| Q3 2014 | $9,292,000 | -18.8% | 717,027 | +2.3% | 0.01% | -25.0% |
| Q2 2014 | $11,438,000 | -9.8% | 700,894 | -2.3% | 0.01% | -14.3% |
| Q1 2014 | $12,679,000 | +84.7% | 717,578 | +153.1% | 0.01% | +75.0% |
| Q4 2013 | $6,864,000 | +143.2% | 283,527 | +255.9% | 0.01% | +166.7% |
| Q3 2013 | $2,822,000 | +336.2% | 79,672 | +92.3% | 0.00% | +200.0% |
| Q2 2013 | $647,000 | – | 41,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |